Series A - Sano Genetics

Series A - Sano Genetics

Investment Firm

Overview

Sano Genetics is a molecular diagnostics company that specializes in developing and commercializing genetic tests for inherited diseases.

Announced Date

Jan 22, 2024

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Plural Platform

Plural Platform

Plural Platform is a early_stage_venture and seed firm.

Participant Investors

4

Investor Name
Participant InvestorPlural Platform
Participant InvestorMMC Ventures
Participant InvestorEpisode 1
Participant InvestorSeedcamp

Round Details and Background

Sano Genetics raised $11371982 on 2024-01-22 in Series A

Sano Genetics is a molecular diagnostics company that specializes in developing and commercializing genetic tests for inherited diseases.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 03, 2023
Grant - Sano Genetics
1-419.6K
Jan 22, 2024
Series A - Sano Genetics
4-11.4M
Jul 02, 2024
Non Equity Assistance - Sano Genetics
1-undefined
May 05, 2017
Grant - Sano Genetics
1-6.5K

Recent Activity

There is no recent news or activity for this profile.